LONGFELLOW INVESTMENT MANAGEMENT CO LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1167487 BOSTON, MA

Position in APGE

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$81,098

New position

Shares Held

611

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#238

of 284 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

LONGFELLOW INVESTMENT MANAGEMENT CO LLC holds $82,537 across 3 Biotechnology names. APGE ranks #1 (98.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc. This page	611	$81,098
2	RNA	Atrium Therapeutics, Inc.	107	$1,439
3	VRXA	Veraxa Biotech Holding AG	194	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$81,098	611	—	Shares	Sole	2026-08-06
No filing history on record for this holder in this stock.